Biomarkers and Lung Cancer Early Detection: State of the Art

Lung cancer burden is increasing, with 2 million deaths/year worldwide. Current limitations in early detection impede lung cancer diagnosis when the disease is still localized and thus more curable by surgery or multimodality treatment. Liquid biopsy is emerging as an important tool for lung cancer...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancers 2021-08, Vol.13 (15), p.3919
Hauptverfasser:	Dama, Elisa, Colangelo, Tommaso, Fina, Emanuela, Cremonesi, Marco, Kallikourdis, Marinos, Veronesi, Giulia, Bianchi, Fabrizio
Format:	Artikel
Sprache:	eng
Schlagworte:	Autoantibodies Biomarkers Biopsy Deoxyribonucleic acid Diagnosis DNA Lung cancer MicroRNAs miRNA Morbidity Mortality Mutation Review Therapeutic targets Tumor cells
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!